Wedbush Starts Acer Therapeutics (ACER) at Outperform
Tweet
Share
E-mailGet Alerts ACER Hot Sheet
Price: $0.90 --0%
Rating Summary:
2 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Rating Summary:
2 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Join SI Premium – FREE
Wedbush analyst Laura Chico initiates coverage on Acer Therapeutics (NASDAQ: ACER) with a Outperform rating and a price target of $48.00.
For an analyst ratings summary and ratings history on Acer Therapeutics click here. For more ratings news on Acer Therapeutics click here.
Shares of Acer Therapeutics closed at $19.71 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Assumes Bravura Solutions Ltd (BVS:AU) at Neutral
- Deutsche Bank Starts Hochtief AG (HOT:GR) (HOCFF) at Hold
- Piper Sandler Starts Unusual Machines (UMAC) at Overweight
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
